| Literature DB >> 30894746 |
Steffi Herold1, Jacqueline Kalb2, Gabriele Büchel2, Carsten P Ade2, Apoorva Baluapuri3, Jiajia Xu2, Jan Koster4, Daniel Solvie2, Anne Carstensen2, Christina Klotz2, Sabrina Rodewald5, Christina Schülein-Völk2, Matthias Dobbelstein5, Elmar Wolf3, Jan Molenaar6, Rogier Versteeg4, Susanne Walz7, Martin Eilers8.
Abstract
MYC is an oncogenic transcription factor that binds globally to active promoters and promotes transcriptional elongation by RNA polymerase II (RNAPII)1,2. Deregulated expression of the paralogous protein MYCN drives the development of neuronal and neuroendocrine tumours and is often associated with a particularly poor prognosis3. Here we show that, similar to MYC, activation of MYCN in human neuroblastoma cells induces escape of RNAPII from promoters. If the release of RNAPII from transcriptional pause sites (pause release) fails, MYCN recruits BRCA1 to promoter-proximal regions. Recruitment of BRCA1 prevents MYCN-dependent accumulation of stalled RNAPII and enhances transcriptional activation by MYCN. Mechanistically, BRCA1 stabilizes mRNA decapping complexes and enables MYCN to suppress R-loop formation in promoter-proximal regions. Recruitment of BRCA1 requires the ubiquitin-specific protease USP11, which binds specifically to MYCN when MYCN is dephosphorylated at Thr58. USP11, BRCA1 and MYCN stabilize each other on chromatin, preventing proteasomal turnover of MYCN. Because BRCA1 is highly expressed in neuronal progenitor cells during early development4 and MYC is less efficient than MYCN in recruiting BRCA1, our findings indicate that a cell-lineage-specific stress response enables MYCN-driven tumours to cope with deregulated RNAPII function.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30894746 PMCID: PMC7611299 DOI: 10.1038/s41586-019-1030-9
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962